This NDC is on FDA's drug shortage list (posted Mar 23, 2018)

Reported reason: Delay in shipping of the drug

Product Information

KETOROLAC 60 MG/2 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.6167 per ML under NDC 63323016202. Its NADAC has been published 646 times since Nov 28, 2013.

FDA first approved this application on Jan 11, 2002. Its Orange Book therapeutic-equivalence code is AP.

KETOROLAC 60 MG/2 ML VIAL

KETOROLAC TROMETHAMINE
$0.6167per ML

Strength

30 mg/mL

NDC

63323016202

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR

Effective Date

10/21/2026

Active Ingredients

KETOROLAC TROMETHAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA075784

FDA Approved

1/11/2002

TE Code

AP

On Market Since

10/18/2000

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitor
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for KETOROLAC 60 MG/2 ML VIAL has been published 646 times since Nov 28, 2013, and over the history we have for it it has risen 50.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6167 per ML
All-time high$1.5377 (Apr 15, 2015)
All-time low$0.3997 (Feb 19, 2014)
52-week high$0.6167
52-week low$0.4543
Median price$0.8975
Average price$0.8866
Largest weekly change+94.1% (Mar 18, 2015)
Weeks tracked646
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+11.6%

3M

+28.3%

6M

+21.2%

1Y

+13.4%

3Y

-13.4%

5Y

-31.3%

All

+50.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of KETOROLAC 60 MG/2 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 60 MG/2 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $0.6167 per ML (NDC 63323016202), effective Nov 11, 2026.

How has the price of KETOROLAC 60 MG/2 ML VIAL changed over time?

Over the history we have for it, the NADAC for KETOROLAC 60 MG/2 ML VIAL has risen 50.6%. It has been tracked across 646 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for KETOROLAC 60 MG/2 ML VIAL?

Since Nov 28, 2013, the NADAC for KETOROLAC 60 MG/2 ML VIAL has ranged from a low of $0.3997 (Feb 19, 2014) to a high of $1.5377 (Apr 15, 2015), with a median of $0.8975 per ML.

Are there cheaper alternatives to KETOROLAC 60 MG/2 ML VIAL?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as KETOROLAC 60 MG/2 ML VIAL in a comparable dosage form, but none are currently priced below it.

Who manufactures KETOROLAC 60 MG/2 ML VIAL?

KETOROLAC 60 MG/2 ML VIAL (NDC 63323016202) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.

Is KETOROLAC 60 MG/2 ML VIAL in shortage?

Yes — NDC 63323016202 is currently listed in FDA's drug shortage database (posted Mar 23, 2018). Reported reason: Delay in shipping of the drug.